Clinical Trials Logo

Clinical Trial Summary

The use of interventions for cancer-related distress is important to reduce this distress. Distress has a negative impact on quality of life, the recovery during and after treatment and may even adversely affect survival. There is insufficient attention to the systematic approach to psychosocial problems in cancer patients in the Netherlands. A task force discussed and studied which instrument measures psychosocial problems best. The distress thermometer ("lastmeter") had the best results. A guideline is written to use the distress thermometer for patients with cancer and will be used in hospitals in the Netherlands. However, it is not clear what the effects are of the use of the distress thermometer on the psychosocial wellbeing of the patient. Furthermore, it is also unknown whether the use of the distress thermometer leads to cost-effective care. The study focuses on the use of the distress thermometer in breast cancer patients. An efficiency study (RCT) will be conducted to evaluate the systematic use of the distress thermometer and its discussion by a nurse as compared to the usual care provided to outpatients who are treated with curative intent for breast cancer by their treating physicians. The clinical and economic impact of the use of the Distress thermometer will be assessed in comparison with usual care.The recruitment of patients will take place in the out-patient clinic of a university hospital. Patients will be followed from diagnose until two years after finishing their treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01091584
Study type Interventional
Source Radboud University
Contact
Status Completed
Phase N/A
Start date March 2010
Completion date July 2016

See also
  Status Clinical Trial Phase
Recruiting NCT04581967 - Study of CYP2C19 and ALDH3A1 Polymorphisms in Breast Cancer Patients
Active, not recruiting NCT05009849 - Role of Exercise in Breast Cancer Patient Undergoing Treatment N/A
Recruiting NCT05809128 - Multidisciplinary Approach to Breast Cancer Through the Study of Altered Transcriptomic and Immune Accompanied by the Identification of Extractable Markers From the Radiodiagnostic Bioimaging
Recruiting NCT03969524 - Functional MRI in Predicting Response to Chemotherapy
Recruiting NCT04480203 - Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions N/A
Recruiting NCT03046238 - Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients Phase 3
Recruiting NCT04654195 - Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient
Completed NCT03771183 - Loreline Study: Characterization of Long Responders Under Eribuline
Recruiting NCT05836077 - Pecha Kucha Method Effects on Posttraumatic Growth and Psychological Resilience N/A